OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $989.02 million. The enterprise value is $1.10 billion.
Important Dates
The next estimated earnings date is Tuesday, February 25, 2025, after market close.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 672.80 million shares outstanding. The number of shares has decreased by -5.19% in one year.
| Current Share Class | 672.80M |
| Shares Outstanding | 672.80M |
| Shares Change (YoY) | -5.19% |
| Shares Change (QoQ) | +43.19% |
| Owned by Insiders (%) | 51.71% |
| Owned by Institutions (%) | 22.89% |
| Float | 256.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.47 |
| Forward PS | 1.53 |
| PB Ratio | 0.71 |
| P/TBV Ratio | 31.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.37.
| Current Ratio | 2.97 |
| Quick Ratio | 2.43 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.44 |
Financial Efficiency
Return on equity (ROE) is -9.39% and return on invested capital (ROIC) is -10.55%.
| Return on Equity (ROE) | -9.39% |
| Return on Assets (ROA) | -8.97% |
| Return on Capital (ROIC) | -10.55% |
| Revenue Per Employee | $181,020 |
| Profits Per Employee | -$34,029 |
| Employee Count | 3,930 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 9.77 |
Taxes
In the past 12 months, OPKO Health has paid $15.88 million in taxes.
| Income Tax | 15.88M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.65% in the last 52 weeks. The beta is 1.63, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | -2.65% |
| 50-Day Moving Average | 1.54 |
| 200-Day Moving Average | 1.41 |
| Relative Strength Index (RSI) | 37.08 |
| Average Volume (20 Days) | 4,276,157 |
Short Selling Information
The latest short interest is 84.80 million, so 12.60% of the outstanding shares have been sold short.
| Short Interest | 84.80M |
| Short Previous Month | 98.57M |
| Short % of Shares Out | 12.60% |
| Short % of Float | 33.12% |
| Short Ratio (days to cover) | 16.72 |
Income Statement
In the last 12 months, OPKO Health had revenue of $711.41 million and -$133.73 million in losses. Loss per share was -$0.19.
| Revenue | 711.41M |
| Gross Profit | 84.38M |
| Operating Income | -309.48M |
| Pretax Income | -244.67M |
| Net Income | -133.73M |
| EBITDA | -209.36M |
| EBIT | -309.48M |
| Loss Per Share | -$0.19 |
Full Income StatementBalance Sheet
The company has $400.08 million in cash and $512.32 million in debt, giving a net cash position of -$112.24 million or -$0.17 per share.
| Cash & Cash Equivalents | 400.08M |
| Total Debt | 512.32M |
| Net Cash | -112.24M |
| Net Cash Per Share | -$0.17 |
| Equity (Book Value) | 1.40B |
| Book Value Per Share | 2.06 |
| Working Capital | 417.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$177.37 million and capital expenditures -$22.62 million, giving a free cash flow of -$199.99 million.
| Operating Cash Flow | -177.37M |
| Capital Expenditures | -22.62M |
| Free Cash Flow | -199.99M |
| FCF Per Share | -$0.30 |
Full Cash Flow StatementMargins
Gross margin is 11.86%, with operating and profit margins of -43.50% and -18.80%.
| Gross Margin | 11.86% |
| Operating Margin | -43.50% |
| Pretax Margin | -16.57% |
| Profit Margin | -18.80% |
| EBITDA Margin | -29.43% |
| EBIT Margin | -43.50% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.19% |
| Shareholder Yield | 5.19% |
| Earnings Yield | -13.52% |
| FCF Yield | -20.22% |
Dividend DetailsAnalyst Forecast
The average price target for OPKO Health is $2.75, which is 87.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.75 |
| Price Target Difference | 87.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.54 |
| Piotroski F-Score | 1 |